This year, MVZ Martinsried celebrates its 25th anniversary, marking a quarter-century of delivering comprehensive and meaningful diagnostic testing to physicians all over Germany
and beyond. This milestone marks the beginning of a new chapter, as MVZ Martinsried embarks on a rebranding journey, further expanding the clinical lab and genetic services under the Medicover brand. This is the culmination of company’s integration into the Medicover group, a process that commenced back in 2019.
“MVZ Martinsried has continually demonstrated great ability to respond to current healthcare needs, making services, technologies, and innovative approaches a reality. We built here a dependable team, with the finest professionals in the field, genuinely interested in the well-being of the patients we serve. We look forward to continuing our journey of innovation and excellence together with Medicover, thus shaping the future of healthcare.”, said Doctor Stefan C. Mehrle, Head of Genetics Business Unit Medicover and Managing
Director, MVZ Martinsried.
The comprehensive rebranding initiative encompasses both facets of operations at MVZ Martinsried. The laboratory operations will be rebranded as Medicover Diagnostics, which will offer an array of tests from allergies and autoimmune conditions to immunology, infectious diseases, and clinical chemistry. At the same time, the genetic practice will adopt the new identity of Medicover Genetics and will provide genetic counselling, and testing services, spanning cytogenetic analyses, molecular pathology, NGS sequencing, and microbiome testing. Serving both in clinical and genetic diagnostics, the company will
continue to provide partners and doctors with rational diagnostic testing and optimal therapy planning for their patients.
Founded in 1998 as an extension of the Institute for Clinical Chemistry at the Ludwig Maximilian University of Munich, MVZ Martinsried has consistently been committed to innovation, progress, and quality. The company continue to invest the same passion in developing its test offering to support partners and doctors all over the world in making the best decisions for their patients.
As part of Medicover, a leading international healthcare and diagnostic services company founded in 1995 and listed on Nasdaq Stockholm, the expertise of MVZ Martinsried
transcends borders. The diagnostic services business of Medicover is conducted through a network of 104 laboratories and 876 blood-drawing points (BDPs) in thirteen countries. More than 10,000 employees are dedicated to serving over 11million patients, performing almost 120 million tests every year.
